John H Kempen

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
    John H Kempen
    Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Ophthalmic Epidemiol 15:47-55. 2008
  2. pmc Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema
    John H Kempen
    Ocular Inflammation Service, Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Ophthalmology 120:1852-9. 2013
  3. pmc Peripapillary choroidal neovascularization in pars planitis
    Sonia Mehta
    Ocular Inflammation Service, Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, 19104, USA
    J Ophthalmic Inflamm Infect 3:13. 2013
  4. pmc Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome
    John H Kempen
    Department of Ophthalmology, and the Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Ophthalmology 119:2343-50. 2012
  5. ncbi request reprint Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis
    John H Kempen
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 113:684-94. 2006
  6. pmc The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics
    John H Kempen
    Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania, 3535 Market Street, Suite 700, Philadelphia, PA 19104, USA
    Am J Ophthalmol 149:550-561.e10. 2010
  7. pmc Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence
    John H Kempen
    Ocular Inflammation Service, Scheie Eye Institute, The University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Am J Ophthalmol 146:802-12.e1. 2008
  8. doi request reprint Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis
    John H Kempen
    Center for Preventive Ophthalmologyand Biostatistics, Department of Ophthalmology, University of Pennsylvania, 3535 Market Street, Suite 700, Philadelphia, PA 19104, USA
    Am J Ophthalmol 146:813-8.e1. 2008
  9. pmc Medical management of human immunodeficiency virus infection
    John H Kempen
    Department of Ophthalmology, the Department of Biostatistics and Epidemiology and the Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Indian J Ophthalmol 56:385-90. 2008
  10. pmc Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study
    John H Kempen
    Ocular Inflammation Service, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA 19104, USA
    BMJ 339:b2480. 2009

Research Grants

Detail Information

Publications62

  1. ncbi request reprint Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
    John H Kempen
    Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Ophthalmic Epidemiol 15:47-55. 2008
    ....
  2. pmc Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema
    John H Kempen
    Ocular Inflammation Service, Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Ophthalmology 120:1852-9. 2013
    ..To evaluate agreement between fluorescein angiography (FA) and optical coherence tomography (OCT) results for diagnosis of macular edema in patients with uveitis...
  3. pmc Peripapillary choroidal neovascularization in pars planitis
    Sonia Mehta
    Ocular Inflammation Service, Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, 19104, USA
    J Ophthalmic Inflamm Infect 3:13. 2013
    ..Here, we describe a case of peripapillary CNV in a patient with intermediate uveitis and explore the pathophysiology and treatment of this condition. This study is a case report and review of the literature...
  4. pmc Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome
    John H Kempen
    Department of Ophthalmology, and the Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Ophthalmology 119:2343-50. 2012
    ..To evaluate cataract risk in eyes of patients with AIDS and cytomegalovirus (CMV) retinitis and to identify risk factors...
  5. ncbi request reprint Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis
    John H Kempen
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 113:684-94. 2006
    ..To evaluate the prevalence of and risk factors for immune recovery uveitis (IRU) in eyes of patients with AIDS and cytomegalovirus (CMV) retinitis...
  6. pmc The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics
    John H Kempen
    Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania, 3535 Market Street, Suite 700, Philadelphia, PA 19104, USA
    Am J Ophthalmol 149:550-561.e10. 2010
    ..To describe the design and methods of the Multicenter Uveitis Steroid Treatment (MUST) trial and the baseline characteristics of enrolled patients...
  7. pmc Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence
    John H Kempen
    Ocular Inflammation Service, Scheie Eye Institute, The University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Am J Ophthalmol 146:802-12.e1. 2008
    ..To critically assess potentially carcinogenic effects of immunosuppressive therapy in the ocular inflammation setting...
  8. doi request reprint Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis
    John H Kempen
    Center for Preventive Ophthalmologyand Biostatistics, Department of Ophthalmology, University of Pennsylvania, 3535 Market Street, Suite 700, Philadelphia, PA 19104, USA
    Am J Ophthalmol 146:813-8.e1. 2008
    ..To evaluate the reproducibility of new criteria for grading the site and activity of intraocular inflammation...
  9. pmc Medical management of human immunodeficiency virus infection
    John H Kempen
    Department of Ophthalmology, the Department of Biostatistics and Epidemiology and the Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Indian J Ophthalmol 56:385-90. 2008
    ..Research is needed to determine the optimal approach for managing cytomegalovirus retinitis in resource-constrained settings...
  10. pmc Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study
    John H Kempen
    Ocular Inflammation Service, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA 19104, USA
    BMJ 339:b2480. 2009
    ..Whether immunosuppressive treatment adversely affects survival is unclear...
  11. pmc Methotrexate for ocular inflammatory diseases
    Sapna Gangaputra
    Department of Ophthalmology, The Fundus Photograph Reading Center, University of Wisconsin, Madison, Wisconsin, USA
    Ophthalmology 116:2188-98.e1. 2009
    ..To evaluate the outcome of treatment with methotrexate for noninfectious ocular inflammation...
  12. pmc Mycophenolate mofetil for ocular inflammation
    Ebenezer Daniel
    The Fundus Photograph Reading Center, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Am J Ophthalmol 149:423-32.e1-2. 2010
    ..To evaluate mycophenolate mofetil as a single noncorticosteroid immunosuppressive treatment for noninfectious ocular inflammatory diseases...
  13. pmc Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial
    John H Kempen
    Ocular Inflammation Service, The University of Pennsylvania, Philadelphia, Philadelphia, PA 19104, USA
    Ophthalmology 118:1916-26. 2011
    ....
  14. pmc Risk of choroidal neovascularization among the uveitides
    Sally L Baxter
    the Scheie Eye Institute, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Am J Ophthalmol 156:468-77.e2. 2013
    ..To evaluate the risk, risk factors, and visual impact of choroidal neovascularization (CNV) in uveitis cases...
  15. pmc Risk of hypotony in noninfectious uveitis
    Ebenezer Daniel
    Scheie Eye Institute, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Ophthalmology 119:2377-85. 2012
    ..We sought to describe the risk and risk factors for hypotony in a noninfectious uveitis cohort...
  16. ncbi request reprint Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment
    Douglas A Jabs
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:780-6. 2007
    ..To report the prevalence of ocular complications of AIDS in the era of highly active antiretroviral therapy (HAART)...
  17. ncbi request reprint Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Jennifer E Thorne
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 113:1441-5. 2006
    ..To quantitate the frequencies of the common causes of visual acuity loss for patients with AIDS and cytomegalovirus (CMV) retinitis in the era of highly active antiretroviral therapy (HAART)...
  18. ncbi request reprint Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment
    Douglas A Jabs
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:787-93. 2007
    ..To report the clinical features on eye examination of patients with AIDS in the era of highly active antiretroviral therapy (HAART)...
  19. pmc Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes
    Douglas A Jabs
    Department of Ophthalmology, The Mount Sinai School of Medicine, New York, New York, USA
    Ophthalmology 117:2152-61.e1-2. 2010
    ..To describe the 5-year outcomes of patients with cytomegalovirus (CMV) retinitis and AIDS in the era of highly active antiretroviral therapy (HAART)...
  20. pmc Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial
    David S Friedman
    Dana Center for Preventive Ophthalmology, The Johns Hopkins University School of Medicine Wilmer Eye Institute, Baltimore, Maryland, USA
    Ophthalmology 120:1571-9. 2013
    ..Secondarily, we sought to explore patient and eye characteristics associated with IOP elevation or nerve damage...
  21. pmc Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases
    Joshua D Udoetuk
    The Ocular Inflammation Service and Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Ophthalmology 119:1569-74. 2012
    ..To identify the incidence and risk factors for corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases...
  22. pmc Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial
    Kevin D Frick
    Department of Health Policy and Management, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Invest Ophthalmol Vis Sci 53:1169-76. 2012
    ....
  23. pmc Cyclosporine for ocular inflammatory diseases
    R Oktay Kaçmaz
    Department of Ophthalmology, The Mount Sinai School of Medicine, New York, New York, USA
    Ophthalmology 117:576-84. 2010
    ..To evaluate the clinical outcomes of cyclosporine treatment for noninfectious ocular inflammation...
  24. ncbi request reprint Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review
    Henry D Jampel
    Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, USA
    Ophthalmology 109:2215-24; quiz 2225, 2231. 2002
    ....
  25. pmc Hypopyon in patients with uveitis
    Ali A Zaidi
    Department of Ophthalmology, The University of Pennsylvania, The Ocular Inflammation Service and Center for Preventive Ophthalmology and Biostatistics, Philadelphia, Pennsylvania, USA
    Ophthalmology 117:366-72. 2010
    ..To evaluate the risk of and risk factors for hypopyon among patients with uveitis and to evaluate the risk of visual changes and complications after hypopyon...
  26. ncbi request reprint Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis
    John H Kempen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, 550 North Broadway, Suite 700, Baltimore, MD 21205, USA
    Am J Ophthalmol 139:1028-34. 2005
    ..To evaluate the risk and risk factors for developing cytomegalovirus (CMV) retinitis in previously uninvolved second eyes among patients with unilateral CMV retinitis...
  27. pmc Azathioprine for ocular inflammatory diseases
    Sirichai Pasadhika
    Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA
    Am J Ophthalmol 148:500-509.e2. 2009
    ..To evaluate treatment outcomes of azathioprine for noninfectious ocular inflammatory diseases...
  28. pmc Factors predictive of remission of new-onset anterior uveitis
    Pichaporn Artornsombudh
    The Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts Department of Ophthalmology, the Scheie Eye Institute, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    Ophthalmology 121:778-84. 2014
    ..To identify factors predictive of remission of inflammation in new-onset anterior uveitis cases treated at tertiary uveitis care facilities...
  29. pmc Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study
    Anthony C Gregory
    Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ophthalmology 120:186-92. 2013
    ..To describe the incidence of and risk factors for visual acuity (VA) loss and ocular complications in patients with juvenile idiopathic arthritis (JIA)-associated uveitis...
  30. pmc High-dose intravenous corticosteroids for ocular inflammatory diseases
    Leon D Charkoudian
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Ocul Immunol Inflamm 20:91-9. 2012
    ..To evaluate the effectiveness and risk of complications of high-dose intravenous pulsed corticosteroids for noninfectious ocular inflammatory diseases...
  31. ncbi request reprint Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS
    Jennifer E Thorne
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:591-8. 2007
    ....
  32. pmc Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema
    Marc H Levin
    Department of Ophthalmology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania
    Ophthalmology 121:588-95.e1. 2014
    ..Among cases of visually significant uveitic macular edema (ME), to estimate the incidence of visual improvement and identify predictive factors...
  33. ncbi request reprint Surgical strategies for coexisting glaucoma and cataract: an evidence-based update
    David S Friedman
    Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland 21287, USA
    Ophthalmology 109:1902-13. 2002
    ..To assess short- and long-term control of intraocular pressure (IOP) with different surgical treatment strategies for coexisting cataract and glaucoma...
  34. pmc Risk of relapse in primary acute anterior uveitis
    Lili Grunwald
    Department of Ophthalmology, The University of Pennsylvania, Philadelphia, PA 19104, USA
    Ophthalmology 118:1911-5. 2011
    ..To evaluate the risk of and risk factors for a second episode (relapse) among patients with remitted primary anterior uveitis...
  35. pmc Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis
    Janet T Holbrook
    Center for Clinical Trials, Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21232, USA
    Am J Ophthalmol 152:628-637.e1. 2011
    ....
  36. ncbi request reprint The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy
    John H Kempen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 110:987-95. 2003
    ..To evaluate the effect of cytomegalovirus (CMV) retinitis on quality of life (QOL) in patients with the acquired immune deficiency syndrome (AIDS)...
  37. ncbi request reprint Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome
    John H Kempen
    Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    Arch Ophthalmol 121:466-76. 2003
    ..To characterize the effect of cytomegalovirus (CMV) retinitis and its treatment on visual acuity in patients with the acquired immunodeficiency syndrome...
  38. ncbi request reprint Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection
    Irene C Kuo
    Department of Ophthalmology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
    Am J Ophthalmol 138:338-46. 2004
    ..To describe the characteristics and outcomes of patients with cytomegalovirus (CMV) retinitis in the absence of human immunodeficiency virus (HIV) infection...
  39. ncbi request reprint Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy
    Douglas A Jabs
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 112:771-9. 2005
    ..To evaluate risk factors for mortality among patients with AIDS in the era of highly active antiretroviral therapy (HAART), particularly the effect of cytomegalovirus (CMV)...
  40. ncbi request reprint Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome
    John H Kempen
    Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 37:1365-73. 2003
    ....
  41. ncbi request reprint The prevalence of diabetic retinopathy among adults in the United States
    John H Kempen
    Department of Ophthalmology, Johns Hopkins School of Medicine, 550 N Broadway, Suite 700, Baltimore, MD 21205, USA
    Arch Ophthalmol 122:552-63. 2004
    ..To determine the prevalence of diabetic retinopathy among adults 40 years and older in the United States...
  42. ncbi request reprint Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Douglas A Jabs
    Wilmer Eye Institute, 550 North Broadway, Suite 700, Baltimore, Maryland 21205, USA
    Am J Ophthalmol 133:48-61. 2002
    ..To describe the characteristics of patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART)...
  43. ncbi request reprint Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Jennifer E Thorne
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 113:1432-40. 2006
    ..To describe the incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus (CMV) retinitis in the era of highly active antiretroviral therapy (HAART)...
  44. ncbi request reprint Birdshot retinochoroidopathy: ocular complications and visual impairment
    Jennifer E Thorne
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21250, USA
    Am J Ophthalmol 140:45-51. 2005
    ..To describe the incidence of vision loss and of ocular complications attributable to birdshot retinochoroidopathy and to describe the association between therapy and the incidence thereof...
  45. ncbi request reprint Vogt-Koyanagi-Harada disease: clinical outcomes
    Irina Bykhovskaya
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Ophthalmol 140:674-8. 2005
    ..To evaluate the effect of treatment on the incidence of vision impairment and structural ocular complications among patients with Vogt-Koyanagi-Harada (VKH) disease...
  46. pmc Response of pediatric uveitis to tumor necrosis factor-α inhibitors
    Melissa A Lerman
    Division of Rheumatology, The Children s Hospital of Philadelphia CHOP, Philadelphia, Pennsylvania 19104, USA
    J Rheumatol 40:1394-403. 2013
    ..To evaluate the outcome of tumor necrosis factor-α inhibition (anti-TNF) for pediatric uveitis...
  47. pmc Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials
    Janet T Holbrook
    Center for Clinical Trials, Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
    Clin Trials 8:736-43. 2011
    ..Randomized clinical trials (RCTs) are an important component of comparative effectiveness (CE) research because they are the optimal design for head-to-head comparisons of different treatment options...
  48. ncbi request reprint The impact of anemia on energy and physical functioning in individuals with AIDS
    Richard D Semba
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Arch Intern Med 165:2229-36. 2005
    ..To our knowledge, the relationship between changes in hemoglobin level and energy and physical functioning in the anemic and "normal" ranges of hemoglobin among individuals with AIDS has not been well characterized...
  49. ncbi request reprint Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis
    Douglas A Jabs
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Ophthalmol 135:26-34. 2003
    ..To evaluate whether cytomegalovirus resistant to ganciclovir, detected in either the blood or urine, correlates with adverse ocular outcomes...
  50. ncbi request reprint Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis
    Angelo P Tanna
    Department of Ophthalmology, Northwestern University Medical School, Chicago, Illinois, USA
    Am J Ophthalmol 136:1009-15. 2003
    ..To determine the incidence of and risk factors for cataract and to describe the visual outcomes of cataract surgery in eyes with cytomegalovirus-related retinal detachments repaired with silicone oil...
  51. ncbi request reprint Mycophenolate mofetil therapy for inflammatory eye disease
    Jennifer E Thorne
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 112:1472-7. 2005
    ..To evaluate treatment outcomes with mycophenolate mofetil in patients with inflammatory eye disease...
  52. ncbi request reprint Disparities in access to medical care for individuals with vision impairment
    Christine Spencer
    School of Public Affairs, University of Baltimore, Baltimore, MD 21202, USA
    Ophthalmic Epidemiol 16:281-8. 2009
    ..We investigated the relationship between blindness and vision impairment and access to medical care...
  53. ncbi request reprint Recurrent nodular scleritis preceding an adult TINU syndrome
    Ebenezer Daniel
    Division of Ocular Immunology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Ocul Immunol Inflamm 14:239-40. 2006
    ..To describe the occurrence of nodular scleritis in a patient developing tubulointerstitial nephritis and uveitis (TINU) syndrome...
  54. ncbi request reprint HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial
    Douglas A Jabs
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    AIDS 16:877-87. 2002
    ..To determine the association of cytomegalovirus (CMV) viremia with mortality and CMV retinitis progression in newly diagnosed and relapsed CMV retinitis...
  55. ncbi request reprint Interobserver agreement in clinical grading of vitreous haze using alternative grading scales
    Dana M Hornbeak
    The Ocular Inflammation Service, Scheie Eye Institute, Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania
    Ophthalmology 121:1643-8. 2014
    ..To evaluate the reliability of clinical grading of vitreous haze using a new 9-step ordinal scale versus the existing 6-step ordinal scale...
  56. ncbi request reprint Methodologic rigor of clinical trials on surgical management of eyes with coexisting cataract and glaucoma
    Henry D Jampel
    Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland 21287 9205, USA
    Ophthalmology 109:1892-901. 2002
    ..To assess the methodologic quality of published studies of the surgical management of coexisting cataract and glaucoma...
  57. ncbi request reprint Retinal vascular occlusion in patients infected with human immunodeficiency virus
    James P Dunn
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Retina 25:759-66. 2005
    ..To describe the clinical features of retinal vascular occlusions (macrovasculopathy) and the proportion of affected patients with human immunodeficiency virus (HIV) infection...
  58. pmc Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors
    Milo A Puhan
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Clin Infect Dis 51:947-56. 2010
    ..We assessed temporal changes in excess mortality and elucidated risk factors for excess mortality in patients with AIDS diagnosed in the era of highly active antiretroviral therapy (HAART)...
  59. ncbi request reprint Economic impact of visual impairment and blindness in the United States
    Kevin D Frick
    Department of Health Policy and Management, Health Services Research and Development Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205 1901, USA
    Arch Ophthalmol 125:544-50. 2007
    ..To assess the economic impact of excess medical and informal care and the health utility loss associated with visual impairment and blindness in adults aged 40 years and older in the United States...
  60. ncbi request reprint The prevalence of refractive errors among adults in the United States, Western Europe, and Australia
    John H Kempen
    Johns Hopkins University School of Medicine, 550 N Broadway, Suite 700, Baltimore, MD 21205, USA
    Arch Ophthalmol 122:495-505. 2004
    ..To estimate the prevalence of refractive errors in persons 40 years and older...
  61. ncbi request reprint Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression
    Larry D Hubbard
    Department of Ophthalmology and Visual Sciences, The University of Wisconsin Medical School, Madison Wisconsin 53711 1068, USA
    Am J Ophthalmol 137:426-34. 2004
    ..To compare grading of cytomegalovirus retinitis progression by two different fundus photograph reading centers (FPRCs)...
  62. ncbi request reprint The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States
    Monique S Roy
    Institute of Ophthalmology and Visual Science, the University of Medicine and Dentistry New Jersey Medical School, 90 Bergen Street, Room 6164, Newark, NJ 07101 1709, USA
    Arch Ophthalmol 122:546-51. 2004
    ..To estimate the US prevalence of diabetic retinopathy (DR) among persons with type 1 diabetes mellitus (DM)...

Research Grants2

  1. QUALITY OF LIFE AND COST EFFECTIVENESS IN CMV RETINITIS
    John Kempen; Fiscal Year: 2002
    ..Subanalyses will assess what factors other than treatment strategy are associated with improved QOL and cost-effectiveness. ..
  2. Complications of Immunosupression for Eye Diseases
    John Kempen; Fiscal Year: 2007
    ..Analysis of the beneficial effects of immunosuppression, based on clinical information only, will be a secondary objective. ..